OBJECTIVE: To estimate the effectiveness against early-onset group B streptococcal (GBS)
disease of intrapartum antibiotic prophylaxis among term and preterm deliveries, deliveries …

OBJECTIVE: To examine published evidence regarding duration of intrapartum antibiotic
prophylaxis administered to pregnant women colonized with group B Streptococcus (GBS) …

Abstract Group B Streptococcus (GBS) emerged as the leading cause of newborn infection
in the United States in the 1970s. In the 1980s clinical trials demonstrated that giving …

Objective: Our purpose was to evaluate the effectiveness of a risk-based intrapartum
antibiotic prophylaxis strategy for the prevention of early-onset neonatal group B …

Background In some countries, up to 30% of women are exposed to intrapartum antibiotic
prophylaxis for prevention of early-onset group B Streptococcal infection. Intrapartum …

Objective. In January 1995, a combined maternal and neonatal protocol for prevention of
early-onset group B streptococcal (GBS) infection was implemented that consisted of a risk …

Background Guidelines issued in 1996 in the United States recommend either screening of
pregnant women for group B streptococcal colonization by means of cultures (screening …

Objective. To identify interventions that reduce the attack rate for early-onset group B
streptococcal (GBS) sepsis in neonates. Study Design. Literature review and reanalysis of …

Can Med Assoc J 1993; 149: 1659-1665 Group B streptococci remain a major cause of
serious bacterial infection in newborns, with early onset disease more prevalent than late …

Objective: We sought to assess the efficacy of a clinical protocol to reduce the incidence of
early-onset neonatal group B Streptococcus (GBS) infection. Study design: We assessed …